move
connect
BRILLIANCE
CELLTIUM visions the prosperity of humanity upon resolute scientific integrity. Our mission at CELLTIUM is to pioneer biotechnology revolutions with the goal to defeat debilitating neurological disorders.

Millions of people are stigmatized with Charcot-Marie-Tooth disease, a collection of rare hereditary peripheral nerve disorders. Around the globe, diabetes and chemotherapy are increasingly common causes of pathological peripheral nerve conditions. We believe that peripheral neuropathy and its associated disability deserve long-overdue public awareness as well as promise for medical breakthroughs.

At CELLTIUM, the uttermost brilliant, connected team is on the move. Our cutting-edge technology and engineering capabilities pave inspiring ways to fulfill our bold and boundless engagement. Especially, our Precision Medicine on key neurological disorders such as Charcot-Marie-Tooth diseases is on the verge of achieving revolutionary scientific milestones. At heart, our innovation will disrupt this emerging market by successfully satisfying unmet medical needs with the first and best medicines. And ours will be among the most exciting R&D stories leaping from conceptualization, through lab benches, ultimately to market places in the foreseeable future.

We CELLTIUM are humbled by the visionary opportunity to change people’s lives. Truly gladly, we appreciate you to join our visionary journey.

May 2020
CELLTIUM INC.